|
2022 Journal Article The authors reply:Reidlinger, Donna M., Johnson, David W., Craig, Jonathan C., McDonald, Stephen P., Mallard, Alistair R., Robison, Laura E., Wong, Germaine and Hawley, Carmel M. (2022). The authors reply:. Kidney International, 102 (6), 1429-1430. doi: 10.1016/j.kint.2022.10.002 |
|
2022 Journal Article Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental StartHegerty, Katharine, Jaure, Allison, Scholes-Robertson, Nicole, Howard, Kirsten, Ju, Angela, Evangelidis, Nicole, Wolley, Martin, Baumgart, Amanda, Johnson, David W., Hawley, Carmel, Reidlinger, Donna, Hickey, Laura, Welch, Alyssa, Cho, Yeoungjee, Kerr, Peter G., Roberts, Matthew A., Shen, Jenny I., Craig, Jonathan, Krishnasamy, Rathika, Viecelli, Andrea and on behalf of the INCremental dialysis to improve Health outcomes people starting Hemodialysis (INCH-HD) investigators (2022). Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start. Kidney International Reports, 8 (3), 478-488. doi: 10.1016/j.ekir.2022.11.012 |
|
2022 Journal Article Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantationPascoe, Elaine M., Chadban, Steven J., Fahim, Magid A., Hawley, Carmel M., Johnson, David W. and Collins, Michael G. (2022). Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation. Trials, 23 (1) 52, 52. doi: 10.1186/s13063-021-05989-w |
|
2022 Journal Article Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practiceViecelli, Andrea K., Teixeira-Pinto, Armando, Valks, Andrea, Baer, Richard, Cherian, Roy, Cippà, Pietro E., Craig, Jonathan C., DeSilva, Ranil, Jaure, Allison, Johnson, David W., Kiriwandeniya, Charani, Kopperschmidt, Pascal, Liu, Wen-J, Lee, Timmy, Lok, Charmaine, Madhan, Krishan, Mallard, Alistair R., Oliver, Veronica, Polkinghorne, Kevan R., Quinn, Rob R., Reidlinger, Donna, Roberts, Matthew, Sautenet, Bénédicte, Hooi, Lai Seong, Smith, Rob, Snoeijs, Maarten, Tordoir, Jan, Vachharajani, Tushar J., Vanholder, Raymond ... on behalf of the VALID Investigator Team (2022). Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice. BMC Nephrology, 23 (1) 372, 1-12. doi: 10.1186/s12882-022-02987-1 |
|
2022 Book Chapter Dialysis dose and adequacy for hemodialysisSmyth, Brendan, Hawley, Carmel M. and Jardine, Meg (2022). Dialysis dose and adequacy for hemodialysis. Evidence-based nephrology. (pp. 20-33) edited by Jonathan C. Craig, Donald A. Molony and Giovanni F. M. Strippoli. Hoboken, NJ USA: John Wiley & Sons. doi: 10.1002/9781119105954.ch41 |
|
2022 Journal Article Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney TransplantationCollins, Michael G., Fahim, Magid A., Pascoe, Elaine M., Hawley, Carmel M., Johnson, David W., Varghese, Julie, Hickey, Laura E., Clayton, Philip A., Gill, John S., Dansie, Kathryn B., McConnochie, Rachael C., Vergara, Liza A., Kiriwandeniya, Charani, Reidlinger, Donna, Mount, Peter F., Weinberg, Laurence, McArthur, Colin J., Toby Coates, P., Endre, Zoltan H., Goodman, David, Howard, Kirsten, Howell, Martin, Jamboti, Jagadish S., Kanellis, John, Laurence, Jerome M., Lim, Wai H., McTaggart, Steven J., O'Connell, Philip J., Pilmore, Helen L. ... on behalf of the BEST-Fluids Investigators and the Australasian Kidney Trials Network (2022). Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation. Transplantation Direct, 8 (12) e1399, 1-13. doi: 10.1097/TXD.0000000000001399 |
|
2022 Conference Publication Baseline Characteristics and Representativeness of the BEST-Fluids Trial Participants: A Randomized Trial of Balanced Crystalloid Solution vs. Saline in Deceased Donor Kidney Transplantation : PUB312Collins, Michael G., Fahim, Magid, Pascoe, Elaine, Clayton, Philip A., Hawley, Carmel, Johnson, David W., Dansie, Kathryn, Varghese, Julie A., McConnochie, Rachael C., Robison, Laura, Reidlinger, Donna, Kiriwandeniya, Charani, Chadban, Steven J. and The BEST Fluids Trial Investigators (2022). Baseline Characteristics and Representativeness of the BEST-Fluids Trial Participants: A Randomized Trial of Balanced Crystalloid Solution vs. Saline in Deceased Donor Kidney Transplantation : PUB312. Kidney Week, Philadelphia, PA United States, 1-5 November 2023. Washington, DC United States: American Society of Nephrology. doi: 10.1681/asn.20223311s1971c |
|
2022 Conference Publication Baseline characteristics and representativeness of the BEST-Fluids trial participants: a randomized trial of balanced crystalloid solution vs. saline in deceased donor kidney transplantationCollins, Michael G., Fahim, Magid, Pascoe, Elaine, Clayton, Philip A., Hawley, Carmel, Johnson, David W., Dansie, Kathryn, Varghese, Julie A., McConnochie, Rachael C., Robison, Laura, Reidlinger, Donna, Kiriwandeniya, Charani and Chadban, Steven J. (2022). Baseline characteristics and representativeness of the BEST-Fluids trial participants: a randomized trial of balanced crystalloid solution vs. saline in deceased donor kidney transplantation. Kidney Week, Orlando, FL USA, 3-6 November 2022. Washington, DC USA: American Society of Nephrology. |
|
2022 Conference Publication EXPERIENCES OF PARTICIPANTS ENROLLED IN A RANDOMIZED CONTROLLED TRIAL OF PRESCRIBED WATER INTAKE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASEAmin, Sneha, Sangadi, Irene, Saravanabavan, Sayanthooran, Munt, Alexandra, Allman-Farinelli, Margaret, Badve, Sunil, Boudville, Neil, Coolican, Helen, Coulshed, Susan, Foster, Sheryl, Fernando, Mangalee, Haloob, Imad, Harris, David, Hawley, Carmel, Holt, Jane, Howell, Martin, Kumar, Karthik, Johnson, David, Lee, Vincent, Lonergan, Maureen, Mai, Jun, Rangan, Anna, Roger, Simon, Sud, Kamal, Tong, Allison, Torres, Vicente, Vilayur, Eswari and Rangan, Gopala (2022). EXPERIENCES OF PARTICIPANTS ENROLLED IN A RANDOMIZED CONTROLLED TRIAL OF PRESCRIBED WATER INTAKE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. HOBOKEN: WILEY. |
|
2022 Conference Publication PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)Saravanabavan, Sayanthooran, Munt, Alexandra, Badve, Sunil, Boudville, Neil, Coolican, Helen, Coulshed, Susan, Foster, Sheryl, Fernando, Mangalee, Haloob, Imad, Harris, David, Hawley, Carmel, Holt, Jane, Howell, Martin, Kumar, Karthik, Johnson, David, Lee, Vincent, Lonergan, Maureen, Mai, Jun, Roger, Simon, Sud, Kamal, Tong, Allison, Torres, Vicente, Vilayur, Eswari and Rangan, Gopala (2022). PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD). HOBOKEN: WILEY. |
|
2022 Conference Publication CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASEKrishnasamy, Rathika, Robison, Laura, Howell, Martin, Howard, Kirsten, Reidlinger, Donna, Shenoy, Aparna, Mallard, Alistair, Pascoe, Elaine, Cho, Yeoungjee, Viecelli, Andrea, Roberts, Matthew, Toussaint, Nigel, Badve, Sunil, Peh, Chen Au, Irish, Ashley, Johnson, Davidw and Hawley, Carmel M. (2022). CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE. HOBOKEN: WILEY. |
|
2022 Conference Publication Baseline characteristics of participants in the NAVKIDS 2trial: a patient navigator program in children with chronic kidney diseaseGuha, Chandana, Khalid, Rabia, Van Zwieten, Anita, Francis, Anna, Hawley, Carmel M., Jaure, Allison, Teixeira-Pinto, Armando, Mallard, Alistair R., Bernier-Jean, Amelie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine M., Ryan, Elizabeth G., Mackie, Fiona, Mccarthy, Hugh J., Craig, Jonathan C., Varghese, Julie, Kiriwandeniya, Charani, Howard, Kirsten, Larkins, Nicholas G., Macauley, Luke, Walker, Amanda, Howell, Martin, Irving, Michelle, Caldwell, Patrina H. Y., Woodleigh, Reginald, Jesudasan, Shilpanjali, Carter, Simon A. ... Wong, Germaine (2022). Baseline characteristics of participants in the NAVKIDS 2trial: a patient navigator program in children with chronic kidney disease. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW Australia, 7-19 October 2022. Richmond, VIC Australia: John Wiley & Sons. |
|
2022 Journal Article Pre-dialysis levels of inflammation and endotoxin in people receiving hemodialysis are not associated with blood pressure variabilityDheda, Shyam, Min, Hongjin, Vesey, David A., Hawley, Carmel, Johnson, David W., Dimeski, Goce, Healy, Helen and Fahim, Magid (2022). Pre-dialysis levels of inflammation and endotoxin in people receiving hemodialysis are not associated with blood pressure variability. Clinical Nephrology, 98 (4), 198-204. doi: 10.5414/CN110656 |
|
2022 Journal Article NAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocolvan Zwieten, Anita, Ryan, Elizabeth G., Caldwell, Patrina, Howard, Kirsten, Tong, Allison, Craig, Jonathan C., Alexander, Stephen I., Howell, Martin, Teixeira-Pinto, Armando, Hawley, Carmel M., Jesudason, Shilpanjali, Walker, Amanda, Mackie, Fiona, Kennedy, Sean E., McTaggart, Steven, McCarthy, Hugh J., Carter, Simon A., Kim, Siah, Woodleigh, Reginald, Francis, Anna, Mallard, Alistair R., Bernier-Jean, Amélie, Johnson, David W., Hahn, Deirdre, Reidlinger, Donna, Pascoe, Elaine, Varghese, Julie, Kiriwandeniya, Charani, Vergara, Liza ... Wong, Germaine (2022). NAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol. Trials, 23 (1) 824. doi: 10.1186/s13063-022-06783-y |
|
2022 Journal Article Synbiotics, prebiotics and probiotics for solid organ transplant recipientsCooper, Tess E., Scholes-Robertson, Nicole, Craig, Jonathan C., Hawley, Carmel M., Howell, Martin, Johnson, David W., Teixeira-Pinto, Armando, Jaure, Allison and Wong, Germaine (2022). Synbiotics, prebiotics and probiotics for solid organ transplant recipients. Cochrane Database of Systematic Reviews, 2022 (9) CD014804, CD014804. doi: 10.1002/14651858.CD014804.pub2 |
|
2022 Journal Article Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTJayne, David, Walsh, Michael, Merkel, Peter A, Peh, Chen Au, Szpirt, Wladimir, Puéchal, Xavier, Fujimoto, Shouichi, Hawley, Carmel, Khalidi, Nader, Jones, Rachel, Flossmann, Oliver, Wald, Ron, Girard, Louis, Levin, Adeera, Gregorini, Gina, Harper, Lorraine, Clark, William, Pagnoux, Christian, Specks, Ulrich, Smyth, Lucy, Ito-Ihara, Toshiko, de Zoysa, Janak, Brezina, Biljana, Mazzetti, Andrea, McAlear, Carol A, Reidlinger, Donna, Mehta, Samir, Ives, Natalie, Brettell, Elizabeth A ... Pusey, Charles D (2022). Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health Technology Assessment, 26 (38), 1-60. doi: 10.3310/pnxb5040 |
|
2022 Journal Article The incidence of cancer recurrence and new cancer following commencement of dialysisLim, Wai H., Ooi, Esther, Pankaj, Aashi, Teixeira-Pinto, Armando, Lin, Yingxin, Johnson, David W., Hawley, Carmel M., Viecelli, Andrea K., Pilmore, Helen, Roberts, Matthew A., Davies, Christopher E., Krishnan, Anoushka and Wong, Germaine (2022). The incidence of cancer recurrence and new cancer following commencement of dialysis. Clinical Kidney Journal, 15 (9), 1770-1781. doi: 10.1093/ckj/sfac124 |
|
2022 Journal Article Dialysis modality utilization patterns and mortality in older persons initiating dialysis in Australia and New ZealandEthier, Isabelle, Campbell, Scott B., Cho, Yeoungjee, Hawley, Carmel M., Isbel, Nicole M., Krishnasamy, Rathika, Roberts, Matthew A., Semple, David, Sypek, Matthew, Viecelli, Andrea K. and Johnson, David W. (2022). Dialysis modality utilization patterns and mortality in older persons initiating dialysis in Australia and New Zealand. Nephrology, 27 (8), 663-672. doi: 10.1111/nep.14073 |
|
2022 Journal Article Perspectives of patients, nurses, and nephrologists about electronic symptom monitoring with feedback in hemodialysis careViecelli, Andrea K., Duncanson, Emily, Bennett, Paul N., D'Antoine, Matilda, Dansie, Kathryn, Handke, William, Tong, Allison, Palmer, Suetonia, Jesudason, Shilpanjali, McDonald, Stephen, Morton, Rachael L., Jose, Matthew, Brown, Chris, Laranjo, Liliana, Caskey, Fergus, Couchoud, Cecile, Johnson, David, Harris, David, Walker, Rachael, Coiera, Enrico, Hawley, Carmel and Simes, R. John (2022). Perspectives of patients, nurses, and nephrologists about electronic symptom monitoring with feedback in hemodialysis care. American Journal of Kidney Diseases, 80 (2), 215-226.e1. doi: 10.1053/j.ajkd.2021.12.007 |
|
2022 Journal Article Implementation strategies for high impact nephrology trials: the end of the trial is just the beginningReidlinger, Donna M., Johnson, David W., Craig, Jonathan C., McDonald, Stephen P., Mallard, Alistair R., Robison, Laura E., Wong, Germaine and Hawley, Carmel M. (2022). Implementation strategies for high impact nephrology trials: the end of the trial is just the beginning. Kidney International, 102 (6), 1222-1227. doi: 10.1016/j.kint.2022.07.006 |
